Yahoo Web Search

Search results

1. • 

     Wall Street Lunch: Lilly In Limelight

     Seeking Alpha· 18 hours ago

     Eli Lilly's tirzepatide reached main goals in two Phase 3 trials for patients with obesity and obstructive sleep apnea. Abbott posts Q1 results beat,...

2. • 

     Hospital Excellence

     New Jersey Business Magazine· 2 days ago

     Englewood Health team members: Leapfrog Group awarded Englewood Health with the title of Pandemic Hero of the Year for its courage and compassion while...

3. • 

     Abbott looks to ‘highly productive’ device pipeline for future growth

     MedTech Dive via Yahoo Finance· 22 hours ago

     CEO Robert Ford highlighted new and upcoming products throughout the earnings call, calling the...

4. • CDC Issues Guidelines for Reopening

     The National Law Review· 5 days ago

     The Centers for Disease Control and Prevention (CDC) recently issued guidance titled “CDC Activities and Initiatives Supporting the COVID-19 response and the President’s Plan for Opening America ...

5. • CDC Relaxes COVID Guidelines; Will Schools, Day Cares Follow Suit?

     North Denver News· 2 hours ago

     Four years after the COVID-19 pandemic closed schools and upended child care, the CDC says parents can start treating the virus like other respiratory illnesses. In case you’ve lost track: Before ...

6. • Healthcare Enforcement Mid-Year Roundup: 2020

     The National Law Review· 1 day ago

     In this installment of the Healthcare Enforcement Roundup we cover new and longstanding issues impacting the healthcare enforcement landscape. First, we explore the impact of the Coronavirus (COVID-19) on the healthcare industry, and the heightened

7. • 

     Labcorp (LH) to Report Q1 Earnings: What's in the Cards?

     Zacks via Yahoo Finance· 2 days ago

     Labcorp (LH) is anticipated to drive growth in the first quarter of 2024 through base business...

8. • 

     Abbott Laboratories narrows 2024 earnings guidance, shares slip By Investing.com

     Investing.com· 21 hours ago

     Abbott Laboratories narrows 2024 earnings guidance, shares slip

9. • 

     We're buying a health-care stock that should be higher after reporting a strong quarter

     CNBC· 20 hours ago

     Shortly after the opening bell, we will be buying 100 shares of Abbott Laboratories at roughly...

10. • COVID-19 and New Jersey’s Immigrants: Frontline Undocumented Immigrant Workers, Financial Ruin, and...

      The National Law Review· 13 hours ago

      A recent report analyzing “the experiences of low-wage immigrant workers and families in New Jersey during the first month of the COVID-19 crisis,” found that “immigrant communities have experienced ...